Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Ground Water|December 8, 2018
Exploring Geological and Topographical Controls on Low Flows with Hydrogeological ModelsClaire Carlier, Stefanie B Wirth, Fabien Cochand, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 2, 2024
Incidence of hand-foot syndrome with protein kinase inhibitors in advanced hepatocellular carcinoma patients who received atezolizumab-bevacizumab combinationMarine Perrier, Emma Zuccaro, Claire Carlier, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 11, 2022
Pesticides and pancreatic adenocarcinoma: A transversal epidemiological, environmental and mechanistic narrative reviewMathias Brugel, Claire Carlier, Gabriela Reyes-Castellanos, et al.Melanoma Research|February 15, 2026
Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3Aurore Devoldere, Olivier Bouche, Coralie Barbe, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 25, 2025
Overcoming language barriers to enhance pharmaceutical care: Design and validation of a pictogram-based tool for cancer patientsJustine Clarenne, Marion Barrois, Audrey Durand, et al.The Oncologist|October 28, 2020
Dramatic Changes in Oncology Care Pathways During the COVID-19 Pandemic: The French ONCOCARE-COV StudyMathias Brugel, Claire Carlier, Christine Essner, et al.Nutrients|November 11, 2022
Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX)Pierre Martin, Damien Botsen, Mathias Brugel, et al.Clinics and Research in Hepatology and Gastroenterology|November 21, 2025
Clinical and economic outcomes of adding durvalumab to gemcitabine/cisplatin in advanced biliary tract cancers: A multicenter descriptive studyLena Luciani, Claire Carlier, Léonie Leuk, et al.Frontiers in Pharmacology|June 5, 2023
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)Antoine Le Bozec, Mathias Brugel, Zoubir Djerada, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 12, 2023
Prevalence of cannabidiol (CBD) consumption and cancer patients' expectations in one oncology day-hospital: A cross-sectional study and questionnaire validationAntoine Le Bozec, Marie Guédon, Mathias Brugel, et al.Pageof 3